Company profile VRCA
After 38 days of this quarter the interest is at 43.0. Based on that we can calculate that during remaining 53 days it will total up to 103.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 109 | 118 8.3% QoQ | 96 -18.6% QoQ | 155 61.5% QoQ |
| 2020 | 30 -72.5% YoY -80.6% QoQ | 88 -25.4% YoY 193.3% QoQ | 197 105.2% YoY 123.9% QoQ | 139 -10.3% YoY -29.4% QoQ |
| 2021 | 120 300.0% YoY -13.7% QoQ | 243 176.1% YoY 102.5% QoQ | 136 -31.0% YoY -44.0% QoQ | 91 -34.5% YoY -33.1% QoQ |
| 2022 | 98 -18.3% YoY 7.7% QoQ | 176 -27.6% YoY 79.6% QoQ | 197 44.9% YoY 11.9% QoQ | 54 -40.7% YoY -72.6% QoQ |
| 2023 | 101 3.1% YoY 87.0% QoQ | 167 -5.1% YoY 65.3% QoQ | 242 22.8% YoY 44.9% QoQ | 109 101.9% YoY -55.0% QoQ |
| 2024 | 43 -57.4% YoY -60.6% QoQ | - | - | - |
The average 5 years interest of Verrica Pharmaceuticals was 10.42 per week. The last year interest of Verrica Pharmaceuticals compared to the last 5 years has changed by 14.2%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 29.49%.
There is not enough data for Verrica Pharmaceuticals Verrica Pharmaceuticals stock to provide analysis
There is not enough data for Verrica Pharmaceuticals Verrica Pharmaceuticals stock to provide correlation calculation
There is not enough data for Verrica Pharmaceuticals Verrica Pharmaceuticals stock to provide analysis
After 38 days of this quarter the interest is at 37.0. Based on that we can calculate that during remaining 53 days it will total up to 89.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 204 inf% QoQ | 230 12.7% QoQ | 162 -29.6% QoQ |
| 2020 | 137 inf% YoY -15.4% QoQ | 81 -60.3% YoY -40.9% QoQ | 26 -88.7% YoY -67.9% QoQ | 167 3.1% YoY 542.3% QoQ |
| 2021 | 197 43.8% YoY 18.0% QoQ | 77 -4.9% YoY -60.9% QoQ | 55 111.5% YoY -28.6% QoQ | 145 -13.2% YoY 163.6% QoQ |
| 2022 | 224 13.7% YoY 54.5% QoQ | 334 333.8% YoY 49.1% QoQ | 127 130.9% YoY -62.0% QoQ | 121 -16.6% YoY -4.7% QoQ |
| 2023 | 96 -57.1% YoY -20.7% QoQ | 138 -58.7% YoY 43.8% QoQ | 120 -5.5% YoY -13.0% QoQ | 124 2.5% YoY 3.3% QoQ |
| 2024 | 37 -61.5% YoY -70.2% QoQ | - | - | - |
The average 5 years interest of VP-102 was 10.78 per week. The last year interest of VP-102 compared to the last 5 years has changed by -8.16%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -29.79%.
After 38 days of this quarter the interest is at 244.0. Based on that we can calculate that during remaining 53 days it will total up to 584.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 357 | 784 119.6% QoQ | 808 3.1% QoQ | 595 -26.4% QoQ |
| 2020 | 516 44.5% YoY -13.3% QoQ | 658 -16.1% YoY 27.5% QoQ | 620 -23.3% YoY -5.8% QoQ | 583 -2.0% YoY -6.0% QoQ |
| 2021 | 697 35.1% YoY 19.6% QoQ | 672 2.1% YoY -3.6% QoQ | 685 10.5% YoY 1.9% QoQ | 539 -7.5% YoY -21.3% QoQ |
| 2022 | 618 -11.3% YoY 14.7% QoQ | 824 22.6% YoY 33.3% QoQ | 851 24.2% YoY 3.3% QoQ | 613 13.7% YoY -28.0% QoQ |
| 2023 | 871 40.9% YoY 42.1% QoQ | 954 15.8% YoY 9.5% QoQ | 990 16.3% YoY 3.8% QoQ | 733 19.6% YoY -26.0% QoQ |
| 2024 | 244 -72.0% YoY -66.7% QoQ | - | - | - |
The average 5 years interest of molluscum contagiosum treatment was 54.66 per week. The last year interest of molluscum contagiosum treatment compared to the last 5 years has changed by 21.81%. The interest for molluscum contagiosum treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 27.28%.
There is not enough data for VP-315 to provide analysis
There is not enough data for VP-315 to provide correlation calculation
There is not enough data for VP-315 to provide analysis
There is not enough data for oncolytic peptide therapy to provide analysis
There is not enough data for oncolytic peptide therapy to provide correlation calculation
There is not enough data for oncolytic peptide therapy to provide analysis
After 38 days of this quarter the interest is at 233.0. Based on that we can calculate that during remaining 53 days it will total up to 558.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 324 | 575 77.5% QoQ | 642 11.7% QoQ | 469 -26.9% QoQ |
| 2020 | 555 71.3% YoY 18.3% QoQ | 455 -20.9% YoY -18.0% QoQ | 463 -27.9% YoY 1.8% QoQ | 443 -5.5% YoY -4.3% QoQ |
| 2021 | 483 -13.0% YoY 9.0% QoQ | 603 32.5% YoY 24.8% QoQ | 554 19.7% YoY -8.1% QoQ | 602 35.9% YoY 8.7% QoQ |
| 2022 | 614 27.1% YoY 2.0% QoQ | 667 10.6% YoY 8.6% QoQ | 642 15.9% YoY -3.7% QoQ | 702 16.6% YoY 9.3% QoQ |
| 2023 | 715 16.4% YoY 1.9% QoQ | 731 9.6% YoY 2.2% QoQ | 679 5.8% YoY -7.1% QoQ | 716 2.0% YoY 5.4% QoQ |
| 2024 | 233 -67.4% YoY -67.5% QoQ | - | - | - |
The average 5 years interest of basal cell carcinoma treatment was 45.64 per week. The last year interest of basal cell carcinoma treatment compared to the last 5 years has changed by 18.03%. The interest for basal cell carcinoma treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 23.73%.
There is not enough data for VP-103 to provide analysis
There is not enough data for VP-103 to provide correlation calculation
There is not enough data for VP-103 to provide analysis
After 38 days of this quarter the interest is at 199.0. Based on that we can calculate that during remaining 53 days it will total up to 477.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 292 | 509 74.3% QoQ | 647 27.1% QoQ | 527 -18.5% QoQ |
| 2020 | 390 33.6% YoY -26.0% QoQ | 641 25.9% YoY 64.4% QoQ | 487 -24.7% YoY -24.0% QoQ | 646 22.6% YoY 32.6% QoQ |
| 2021 | 448 14.9% YoY -30.7% QoQ | 643 0.3% YoY 43.5% QoQ | 459 -5.7% YoY -28.6% QoQ | 347 -46.3% YoY -24.4% QoQ |
| 2022 | 481 7.4% YoY 38.6% QoQ | 569 -11.5% YoY 18.3% QoQ | 488 6.3% YoY -14.2% QoQ | 485 39.8% YoY -0.6% QoQ |
| 2023 | 646 34.3% YoY 33.2% QoQ | 830 45.9% YoY 28.5% QoQ | 723 48.2% YoY -12.9% QoQ | 606 24.9% YoY -16.2% QoQ |
| 2024 | 199 -69.2% YoY -67.2% QoQ | - | - | - |
The average 5 years interest of plantar warts treatment was 42.55 per week. The last year interest of plantar warts treatment compared to the last 5 years has changed by 25.5%. The interest for plantar warts treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 27.66%.